Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periarticular dextrose prolotherapy plus ozone for knee osteoarthritis
IRCT20190415043279N8Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dextrose, medical ozonated water and lidocaine in knee osteoarthritis (OA) (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Intensity of pain, Physical function and 2 more. Started Mar 2020; status: completed.
02
Drugs
dextrosemedical ozonated waterlidocaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20190415043279N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190415043279N8.